Main Article Content
Record ID: 117
Type: Poster Presentation (in-person)
Advisor: Paul Lewis
Abstract: Hemoglobin A1c is currently the “gold standard” used to assess long term glycemic control in diabetics. Time in range (TIR) is an alternative, more reliable method used to assess glycemic control by determining the percentage of time spent in the target glucose range (70-180 mg/dL). TIR is measured via continuous glucose monitoring (CGM) and offers benefits that Hemoglobin A1c lacks such as convenience, improved accuracy, and the ability to assess hypoglycemia. The purpose of our capstone project is to educate Type 1 diabetic families using CGM about the benefits of using TIR vs Hemoglobin A1c, therefore, advocating to utilize TIR at home to manage the chronic disease rather than the traditional use of Hemoglobin A1c. Our project sought out the evidence through a thorough literature search. Using this evidence, we developed an educational seminar to present to families of Type 1 diabetics with a powerpoint presentation and an educational brochure. Our pretest and posttest will measure knowledge gained and willingness of patients to change their own practice. Our outcomes are pending as we await to present our research findings. As a group, we have learned to be more in touch with issues that do not directly affect us, but affect our loved ones. We, too, can use our voices and education to advocate for changes that will benefit diabetics, including our fellow group member Annabelle Gonnella.